Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-338 for functional dyspepsia
ACTRN12605000794606Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acotiamide in functional dyspepsia (FD) (2 arms), sponsored by Zeria Pharmaceutical Co., Ltd. Primary endpoint: Improvement of meal-related symptoms. Started Feb 2006; status: completed.
02
Drugs
acotiamide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ACTRN12605000794606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000794606.